Identification of pathogenesis-associated genes by T-DNA-mediated insertional mutagenesis in Botrytis cinerea: a type 2A phosphoprotein phosphatase and an SPT3 transcription factor have significant impact on virulence.

Agrobacterium tumefaciens-mediated transformation (ATMT) was used to generate an insertional mutant library of the gray mold fungus Botrytis cinerea. From a total of 2,367 transformants, 68 mutants showing significant reduction in virulence on tomato and bean plants were analyzed in detail. As reported for other fungal ATMT libraries, integrations were mostly single copy, occurred preferentially in noncoding (regulatory) regions, and were frequently accompanied by small deletions of the target sequences and loss of parts of the border sequence. Two T-DNA integration events that were found to be linked to virulence were characterized in more detail: a catalytic subunit of a PP2A serine/threonine protein phosphatase (BcPP2Ac) and the SPT3 subunit of a Spt-Ada-Gcn5-acetyltransferase (SAGA-like) transcriptional regulator complex. Gene replacement and silencing approaches revealed that both Bcpp2Ac and SPT3 are crucial for virulence, growth, and differentiation as well as for resistance to H(2)O(2) in B. cinerea.

The Xylanolytic System of Claviceps purpurea: Cytological Evidence for Secretion of Xylanases in Infected Rye Tissue and Molecular Characterization of Two Xylanase Genes.

ABSTRACT Claviceps purpurea is a common phytopathogenic fungus that colonizes ovarian tissue of grasses. A concerted approach involving cytological and molecular techniques was initiated to investigate the role of the fungus' xylanolytic system in the interaction. Using enzyme-gold and immuno-gold electron-microscopic techniques, the presence of arabinoxylans in cell walls of rye ovarian tissues (i.e., along the usual path of infection of C. purpurea) was confirmed; tissue-print and immunostaining analyses indicated the presence of xylanase(s) exclusively in ovaries infected with C. purpurea. This strongly suggests that C. purpurea secretes xylanase while colonizing its host. Two xylanase genes (cpxyl1 and cpxyl2) were isolated from a genomic library of C. purpurea using genes from Cochliobolus carbonum (xyl1) and Magnaporthe grisea (xyn33) as heterologous probes. cpxyl1 of C. purpurea had an open reading frame (ORF) of 832 bp interrupted by a 181-bp intron. The derived gene product (CPXYL1) had a molecular mass of 21.5 kDa and an pI of 8.88; it showed significant homology to family G endo-beta-1,4-xylanases. The cpxyl2 ORF (1,144 bp) contained two introns (76 and 90 bp) and coded for a polypeptide of 33.8 kDa with an pI of 7.01; CPXYL2 belonged to family F xylanases. Southern analyses with genomic DNA demonstrated that both genes were single-copy genes. Using reverse transcription polymerase chain reaction, it could be shown that both genes were expressed in vitro and in planta (during all infection stages). Inactivation of cpxyl1 was achieved by a gene-replacement approach. The mutant strain (Deltacpxyl1) had significantly reduced xylanase activity; Western analyses confirmed that it lacked a polypeptide of approximately 23 kDa.

Acute leukemias express a functional receptor for the human growth hormone.

The potential influence of the human growth hormone (hGH) on the behavior of acute leukemias is a matter of controversy. We investigated primary childhood and adult leukemias (n = 44) and leukemic cell lines (n = 13) for the expression of the hGH receptor (hGHR) by immunohistochemistry and flow cytometry. All leukemias expressed the hGHR in the cytoplasm; expression on the surface was undetectable in some of the leukemias. In leukemic cell lines, hGHR expression on the surface was demonstrated in a dose-dependent manner after incubation with rhGH. Physiologic concentrations of hGH were more efficient than higher doses in increasing hGHR surface expression. A proliferative response to hGH was accomplished in cell lines REH, Molt4, and K562. However, only one of 19 primary leukemias (ALL, n = 12; AML, n = 7) showed increased cell counts after the addition of 50-800 ng/ml recombinant hGH (rhGH). These cells were of an immature T-cell phenotype. We thus conclude that acute leukemias can be stimulated by hGH to up-regulate its receptor, but that most primary leukemias may require additional signals for the induction of proliferation.